مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,996
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

TREATMENT OF HYPERTROPHIC SCAR WITH INTRALESIONAL INJECTION OF BOTULINUM TOXIN A: A DOUBLE-BLIND, RANDOMIZED CONTROLLED CLINICAL TRIAL

Pages

  10-16

Abstract

 Background and Aim: HYPERTROPHIC SCARs are highly resistant to the treatment and have a high recurrence rate. Affected patients suffer from aesthetic and functional complications, which may influence their quality of life. Nowadays, various therapeutic modalities have been used in the treatment of HYPERTROPHIC SCARs, but patients' problems remain because of high recurrence rate. This study evaluated the efficacy of INTRALESIONAL INJECTION of BOTULINUM TOXIN A in the treatment of HYPERTROPHIC SCAR lesions.Methods: This randomised controlled trial was performed during 2014 and 2015. Each patient’s lesion was randomly allocated in ine of the two arms of the study: one half of the lesion received monthly 8 IU/cm3 of 200 IU/ml intralesional BOTULINUM TOXIN A (Dysport, Ipsen Biopharma Ltd., UK) and the other half was injected with the same volume of normal saline. Injections were repeated three times. After 9 months, lesions were evaluated according to Vancouver scar scale.Results: Twenty-one patients with a mean age of 27.2 years completed the study. In the intervention the mean lesions` pigmentation scale decrease to 0.73, vascularity to 0.9 and pliability to 0.98 (P<0.01), but there was no significant change in lesions height (P=0.32).Conclusion: It seems that injection of BOTULINUM TOXIN A in HYPERTROPHIC SCAR lesions acts as useful adjuvant for other treatment methods.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    TAHERI, AHMAD REZA, KHORASANI, GHASEM ALI, FORGHANI, SIAMAK, & FATHI, AFSHIN. (2016). TREATMENT OF HYPERTROPHIC SCAR WITH INTRALESIONAL INJECTION OF BOTULINUM TOXIN A: A DOUBLE-BLIND, RANDOMIZED CONTROLLED CLINICAL TRIAL. DERMATOLOGY AND COSMETIC, 7(1), 10-16. SID. https://sid.ir/paper/157546/en

    Vancouver: Copy

    TAHERI AHMAD REZA, KHORASANI GHASEM ALI, FORGHANI SIAMAK, FATHI AFSHIN. TREATMENT OF HYPERTROPHIC SCAR WITH INTRALESIONAL INJECTION OF BOTULINUM TOXIN A: A DOUBLE-BLIND, RANDOMIZED CONTROLLED CLINICAL TRIAL. DERMATOLOGY AND COSMETIC[Internet]. 2016;7(1):10-16. Available from: https://sid.ir/paper/157546/en

    IEEE: Copy

    AHMAD REZA TAHERI, GHASEM ALI KHORASANI, SIAMAK FORGHANI, and AFSHIN FATHI, “TREATMENT OF HYPERTROPHIC SCAR WITH INTRALESIONAL INJECTION OF BOTULINUM TOXIN A: A DOUBLE-BLIND, RANDOMIZED CONTROLLED CLINICAL TRIAL,” DERMATOLOGY AND COSMETIC, vol. 7, no. 1, pp. 10–16, 2016, [Online]. Available: https://sid.ir/paper/157546/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top